IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 41 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $333,875 | 0.0% | 360,000 | 0.0% | 0.00% | – |
| Q1 2023 | $333,875 | -84.9% | 360,000 | -84.7% | 0.00% | -100.0% |
| Q3 2022 | $2,216,000 | +24522.2% | 2,350,000 | +23400.0% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 10,000 | -33.3% | 0.00% | – |
| Q3 2021 | $14,000 | -99.7% | 15,000 | -99.7% | 0.00% | -100.0% |
| Q2 2021 | $4,385,000 | +974.8% | 4,761,000 | +1090.2% | 0.00% | – |
| Q4 2020 | $408,000 | – | 400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 65,391,000 | $67,089,000 | 4.52% |
| DeepCurrents Investment Group LLC | 79,644,000 | $81,053,000 | 2.13% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 76,017,000 | $78,229,000 | 1.67% |
| Opti Capital Management, LP | 12,900,000 | $13,223,000 | 1.47% |
| CAMDEN ASSET MANAGEMENT L P /CA | 37,474,000 | $38,245,000 | 1.32% |
| Soleus Capital Management, L.P. | 8,500,000 | $8,675,000 | 1.14% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 33,000,000 | $33,861,000 | 0.95% |
| AQR Arbitrage LLC | 21,200,000 | $21,742,000 | 0.76% |
| III Capital Management | 4,600,000 | $4,734,000 | 0.60% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,621,000 | $4,774,000 | 0.50% |